Effect of Radiofrequency in Women With Chronic Pelvic Pain With an Associated Myofascial Syndrome Versus Myofascial Therapy and no Treatment

Last updated: March 26, 2025
Sponsor: Hospital Clinic of Barcelona
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dysmenorrhea (Painful Periods)

Chronic Pelvic Pain

Interstitial Cystitis

Treatment

Radiofrequency therapy

myofascial manual therapy

Clinical Study ID

NCT06908200
HCB/2021/0313
HCB/2021/0313
  • Ages > 18
  • Female

Study Summary

A randomised clinical trial is being conducted in the Gynecology Department of the Hospital Clinic de Barcelona in women presenting chronic pelvic pain syndrome due to a myofascial cause which is over a 4 score in the VAS scale and not related to an obstetric injury. This study presents 4 groups; two groups receive 8 radiofrequency sessions, one group receives 8 sessions of myofascial release therapy (MRT) and the last group receives no treatment at all (NT). The two RF groups have been divided into a RF intervention group (RFIG) and a RF control group (RFCG) which receives sham treatment. The RF groups are double-blinded. Other than RF, both groups perform daily Thiele massage at home. The sessions last for 20 minutes and take place once a week during 8 weeks.

The main variable evaluated is the level of pain during the muscular assessment carried out by an expert pelvic floor physical therapist using the Verbal numeric Scale in the first session and at the end of the 8 sessions. Secondary variables are: sexual function (throughout FSFI questionnaire), pain catastrophizing (ECD), quality of life (EQ5D), anxiety and depression (HADS), central sensitization (CSI) as well as other pelvic floor dysfunction symptoms (PFDI).

Eligibility Criteria

Inclusion

Inclusion criteria included women who were:

  • At least 18 years of age

  • Presenting with pelvic pain persisting for at least 6 months

  • Diagnosed with myofascial syndrome of the pelvic floor muscles (PFM) by a specialist based on physical assessment

  • Presenting with pelvic pain intensity greater than 4 on the Visual Analog Scale (VAS) in the last 3 months

  • Agreed to sign the informed consent form.

Exclusion criteria included the following:

  • Patients who were pregnant

  • Postpartum patients who had given birth within the last year

  • Patients with a history of vulvovaginal pathology

  • Contraindications for the use of radiofrequency: metal implants or active infection

  • Patients with a history of pelvic cancer, including those who had undergone chemotherapy, radiotherapy, and/or brachytherapy.

Study Design

Total Participants: 80
Treatment Group(s): 2
Primary Treatment: Radiofrequency therapy
Phase:
Study Start date:
May 10, 2022
Estimated Completion Date:
June 15, 2025

Connect with a study center

  • Hospital Clinic de Barcelona

    Barcelona, 08036
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.